A2ZT34 logo

Azenta BOVESPA:A2ZT34 Stock Report

Last Price

R$22.08

Market Cap

R$14.2b

7D

0%

1Y

26.2%

Updated

23 May, 2024

Data

Company Financials +

A2ZT34 Stock Overview

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

A2ZT34 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Azenta, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Azenta
Historical stock prices
Current Share PriceUS$22.08
52 Week HighUS$28.51
52 Week LowUS$17.88
Beta1.51
1 Month Change0%
3 Month Change-18.94%
1 Year Change26.24%
3 Year Changen/a
5 Year Changen/a
Change since IPO-41.03%

Recent News & Updates

Recent updates

Shareholder Returns

A2ZT34BR Life SciencesBR Market
7D0%0%0%
1Y26.2%0%0%

Return vs Industry: A2ZT34 exceeded the BR Life Sciences industry which returned 0.9% over the past year.

Return vs Market: A2ZT34 exceeded the BR Market which returned 6.9% over the past year.

Price Volatility

Is A2ZT34's price volatile compared to industry and market?
A2ZT34 volatility
A2ZT34 Average Weekly Movementn/a
Life Sciences Industry Average Movement0%
Market Average Movement0%
10% most volatile stocks in BR Market0%
10% least volatile stocks in BR Market0%

Stable Share Price: A2ZT34 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine A2ZT34's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19783,400Steve Schwartzwww.azenta.com

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions.

Azenta, Inc. Fundamentals Summary

How do Azenta's earnings and revenue compare to its market cap?
A2ZT34 fundamental statistics
Market capR$14.18b
Earnings (TTM)-R$785.00m
Revenue (TTM)R$3.36b

4.2x

P/S Ratio

-18.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A2ZT34 income statement (TTM)
RevenueUS$651.76m
Cost of RevenueUS$386.23m
Gross ProfitUS$265.53m
Other ExpensesUS$417.79m
Earnings-US$152.26m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-2.82
Gross Margin40.74%
Net Profit Margin-23.36%
Debt/Equity Ratio0%

How did A2ZT34 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.